Local Wound Infiltration in Renal Surgery
Overview
Multimodal analgesia is a rational approach to treat various components of postoperative pain.
Full Title of Study: “Effect of Local Wound Infiltration Plus Usual Care Versus Usual Care Alone on Pain Relief After Open Renal Surgery.”
Study Type
- Study Type: Interventional
- Study Design
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Primary Purpose: Prevention
- Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
- Study Primary Completion Date: December 2018
Detailed Description
Local anesthetic wound infiltration is widely recognized as a useful adjunct during multimodal postoperative pain management whether given before operation or perioperatively.
Interventions
- Drug: local wound infiltration plus usual care
- local wound infiltration plus usual care
- Drug: usual care only
- usual care only
Arms, Groups and Cohorts
- Active Comparator: Local wound infiltration
- local wound infiltration plus usual care
- Placebo Comparator: Control
- usual care only
Clinical Trial Outcome Measures
Primary Measures
- Postoperative pain
- Time Frame: The first 48 hours after surgery
- Visual analogue scale ranging from 0-10 cm where 0 cm = no pain and 10 cm = the worst imaginable pain.
Participating in This Clinical Trial
Inclusion Criteria
- ASA I or II, aged between 30 and 65 yr, and undergoing open renal surgery Exclusion Criteria:
- history of adverse reactions to local anaesthetics, chronic hepatic disease, chronic renal disease chronic pain, chronic preoperative opioid consumption, psychiatric disorders which would prevent postoperative assessments,
Gender Eligibility: All
Minimum Age: 30 Years
Maximum Age: 65 Years
Are Healthy Volunteers Accepted: No
Investigator Details
- Lead Sponsor
- Assiut University
- Provider of Information About this Clinical Study
- Principal Investigator: Seham Mohamed Moeen Ibrahim, lecturer – Assiut University
- Overall Contact(s)
- Seham M Moeen, MD, 2413201, seham.moeen@yahoo.com
Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.